 This study investigated the effects of omega-3 supplementation on uremic poritis in chronic hemodialysis patients. The results showed that the mean score of itching decreased significantly in both the intervention and the placebo group, with the difference being statistically significant between the two groups. Therefore, the authors concluded that omega-3 supplementation can be used as a therapeutic option for reducing uremic poritis in chronic hemodialysis patients.